HSA
FLGT icon

Hussman Strategic Advisors’s Fulgent Genetics FLGT Stock Holding History

Hussman Strategic Advisors’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-15,500
Closed -$484K – 309
2023
Q1 		$484K Hold
15,500
– – 0.08% 278
2022
Q4 		$462K Hold
15,500
– – 0.08% 261
2022
Q3 		$591K Hold
15,500
– – 0.1% 246
2022
Q2 		$845K Hold
15,500
– – 0.15% 219
2022
Q1 		$967K Hold
15,500
– – 0.19% 183
2021
Q4 		$1.56M Hold
15,500
– – 0.34% 111
2021
Q3 		$1.39M Buy
15,500
+6,200
+67% +$564K 0.31% 129
2021
Q2 		$858K Buy
+9,300
New +$743K 0.18% 202

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Hussman Strategic Advisors's FLGT Position: Q2 2023 in Review

Hussman Strategic Advisors sold out of Fulgent Genetics (FLGT) in Q2 2023, closing a stake of 15,500 shares — an estimated $484K sold.

Hussman Strategic Advisors first reported a position in FLGT in Q2 2021 and held it in 8 quarters. The position peaked at $1.56M in Q4 2021. 214 funds tracked by Wall St. Rank hold FLGT as of Q2 2023.

  • Hussman Strategic Advisors reported no remaining Fulgent Genetics position as of Q2 2023 after selling out during the quarter.
  • Hussman Strategic Advisors sold 15,500 Fulgent Genetics shares in Q2 2023, an estimated $484K.
  • Hussman Strategic Advisors first reported a position in Fulgent Genetics in Q2 2021 and held it in 8 quarters.
  • Hussman Strategic Advisors's Fulgent Genetics position peaked at $1.56M in Q4 2021.
  • 214 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2023.

Based on Hussman Strategic Advisors's 13F filing for Q2 2023, filed 3 Aug 2023.